DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:CPR - NL0015435975 - Common Stock
6.098 EUR
0 (-0.03%)
CPR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 30 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, CPR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- CPR had positive earnings in the past year.
- CPR had a positive operating cash flow in the past year.
- Each year in the past 5 years CPR has been profitable.
- In the past 5 years CPR always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.51%, CPR is doing worse than 63.33% of the companies in the same industry.
- With a Return On Equity value of 5.44%, CPR is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
- CPR has a Return On Invested Capital (7.03%) which is comparable to the rest of the industry.
- CPR had an Average Return On Invested Capital over the past 3 years of 7.66%. This is in line with the industry average of 8.18%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
- Looking at the Profit Margin, with a value of 6.57%, CPR is in line with its industry, outperforming 43.33% of the companies in the same industry.
- CPR's Profit Margin has declined in the last couple of years.
- CPR's Operating Margin of 21.32% is fine compared to the rest of the industry. CPR outperforms 63.33% of its industry peers.
- In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
- CPR has a Gross Margin of 57.55%. This is in the better half of the industry: CPR outperforms 76.67% of its industry peers.
- CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
- Compared to 1 year ago, CPR has more shares outstanding
- The number of shares outstanding for CPR has been increased compared to 5 years ago.
- CPR has about the same debt/assets ratio as last year.
2.2 Solvency
- CPR has an Altman-Z score of 2.62. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.62, CPR is doing good in the industry, outperforming 76.67% of the companies in the same industry.
- The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of CPR (8.49) is comparable to the rest of the industry.
- CPR has a Debt/Equity ratio of 0.64. This is a neutral value indicating CPR is somewhat dependend on debt financing.
- The Debt to Equity ratio of CPR (0.64) is better than 63.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.62 |
ROIC/WACC1.03
WACC6.79%
2.3 Liquidity
- A Current Ratio of 2.32 indicates that CPR has no problem at all paying its short term obligations.
- CPR has a better Current ratio (2.32) than 83.33% of its industry peers.
- CPR has a Quick Ratio of 2.32. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.91, CPR is in the better half of the industry, outperforming 76.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
- CPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.50%.
- Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
- CPR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.18%.
- CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
- CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.51% yearly.
- CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.25% yearly.
EPS Next Y2.03%
EPS Next 2Y4.85%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 35.87, CPR can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, CPR is valued a bit more expensive than the industry average as 76.67% of the companies are valued more cheaply.
- The average S&P500 Price/Earnings ratio is at 27.32. CPR is valued slightly more expensive when compared to this.
- A Price/Forward Earnings ratio of 18.68 indicates a rather expensive valuation of CPR.
- CPR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 63.33% of the companies in the same industry.
- CPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.30, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.87 | ||
| Fwd PE | 18.68 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as CPR.
- CPR's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CPR is more expensive than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.4 | ||
| EV/EBITDA | 12.2 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)17.69
PEG (5Y)N/A
EPS Next 2Y4.85%
EPS Next 3Y7.34%
5. Dividend
5.1 Amount
- CPR has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
- CPR's Dividend Yield is slightly below the industry average, which is at 2.61.
- CPR's Dividend Yield is slightly below the S&P500 average, which is at 1.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
5.2 History
- The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 38.69% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.69%
EPS Next 2Y4.85%
EPS Next 3Y7.34%
BIT:CPR (1/22/2026, 3:06:35 PM)
6.098
0 (-0.03%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-29 2025-10-29
Earnings (Next)03-04 2026-03-04/amc
Inst Owners23.2%
Inst Owner ChangeN/A
Ins Owners50.8%
Ins Owner ChangeN/A
Market Cap7.51B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts72.31
Price Target7.05 (15.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.15% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.44%
PT rev (3m)1.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.87 | ||
| Fwd PE | 18.68 | ||
| P/S | 2.45 | ||
| P/FCF | 23.4 | ||
| P/OCF | 11.51 | ||
| P/B | 2.02 | ||
| P/tB | 61.85 | ||
| EV/EBITDA | 12.2 |
EPS(TTM)0.17
EY2.79%
EPS(NY)0.33
Fwd EY5.35%
FCF(TTM)0.26
FCFY4.27%
OCF(TTM)0.53
OCFY8.69%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)17.69
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.62 |
F-Score6
WACC6.79%
ROIC/WACC1.03
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.03%
EPS Next 2Y4.85%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year26.24%
EBIT Next 3Y12.26%
EBIT Next 5Y10.28%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status for CPR stock?
ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.
Can you provide the financial health for CPR stock?
The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.
Can you provide the expected EPS growth for CPR stock?
The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 2.03% in the next year.